No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home REAL ESTATE

Builds Bio+ Releases New York / London Life Sciences Study Tour Research Report

Business Wireby Business Wire
March 13, 2024
Reading Time: 6 mins read
in REAL ESTATE, UK&IRELAND
Share on FacebookShare on Twitter

Life Science Subclusters are Forming Across all of New York City’s Boroughs and Surrounding Areas, Signifying an Important Strategic Development Within the City’s Burgeoning Life Sciences Landscape

The 2024 Study Tour to be Hosted in London

NEW YORK–(BUSINESS WIRE)–#BuildsBio–Builds Bio+, the premier life science membership organization that connects all segments of the life sciences ecosystem across major regional clusters, today announced the release of its New York / London Life Sciences Study Tour research report, titled “Evolution of the New York Life Sciences Market.” The report traces the evolution and growth of the New York City (NYC) life sciences market over the last 25 years, highlighting the development of key infrastructure and initiatives that have contributed to the city’s emergence as a global leader in research and innovation, and offering lessons learned for other cities that aim to become an innovative life science hub.


Parallel Strategies with Regional Life Science Subclusters

Regional life science subclusters have formed across all of NYC’s boroughs, serving as hubs for innovation and collaboration. Similarly, regional subclusters are developing across London, mirroring NYC’s trajectory. Because of these parallels—and also given the qualitative similarities between the two cities as international centers of finance and culture with some of the world’s finest academic and research institutions—Builds Bio+ forged a partnership with stakeholders from the London life sciences community to exchange lessons learned and identify future growth opportunities. This partnership set the stage for a three-day immersive experience that took place in NYC and culminated in the research report.

NYC’s Life Science Growth Offers Lessons Learned for Global Ecosystems

“NYC has made tremendous advances in the six years that Builds Bio+ has been bringing the life science ecosystem together to support the growth of this important industry,” said Nancy J Kelley, president and chief executive officer of Nancy J Kelley + Associates, a founding member of Builds Bio+. “In just 2018, the shortage of affordable commercial laboratory space in the City made it difficult to retain young companies spinning out of the research institutions, and today three million square feet of laboratory space has already been built. This is a great achievement for Builds Bio+, New York City Economic Development Corporation (NYCEDC), New York State Empire State Development, and the numerous other public-private real estate and life science partnerships that have come together to build this ecosystem.”

The report provides an overview of each of NYC’s life science subclusters, including Mount Sinai and Academic Alley, Long Island City, Kips Bay (Midtown East), Brooklyn, Hudson Square/Downtown, Jersey City and Newark, NJ, Midtown West, West Harlem, and The Bronx. Each of these regions contain state-of-the-art facilities and collaborative environments necessary to foster innovation.

The lessons learned for other cities emphasize the need for not only academic excellence, but also an engine for commercialization and growth, including a supportive and flexible infrastructure tailored to a diverse set of technological needs and company sizes, local leadership, and robust workforce development programs.

Builds Bio+ Announces Dates for the 2024 Study Tour to be Hosted in London

“The exchange of ideas that took place throughout the Life Sciences Study Tour provided valuable perspectives on market growth in NYC and highlighted exciting future opportunities for development and collaboration. To hear first-hand the various bold initiatives taken by NYC and the State of NY to support the industry in a challenging market provides helpful guidance for cities such as London,” said Ryan Matenchuk, Managing Director, Galileo Labs. “We look forward to hosting the 2024 Life Sciences Study Tour in London this April, where we will discuss the evolution of the London UK life sciences market and host site tours of leading European life science facilities across London, Cambridge, and Oxford. We look forward to issuing a similar report focused on the London UK market after this important event.”

The New York / London Life Sciences Study Tour will continue in London, UK on April 22-25, 2024. For more information, please visit: https://buildsbio.org/london-life-sciences-study-tour-2024/

About Builds Bio+

Builds Bio+ is a membership-driven organization dedicated to educating and connecting life science and real estate professionals, with a focus on enhancing visibility and innovation, and fostering economic growth within major regional clusters. Through curated events, comprehensive research, industry reports, and educational programs, Builds Bio+ serves as a central hub for the life sciences innovation community. Builds Bio+ was co-founded by Nancy J Kelley + Associates, Jaros, Baum & Bolles, Fried Frank, Hunter Roberts Construction Group, and Sabey Data Center Properties. To learn more, visit https://buildsbio.org, and follow us on LinkedIn, Instagram, and YouTube.

Contacts

Tracy Lessor, TLOW Communications, LLC

tracy@tlowcommunications.com
617.519.9827

Read the orginal article: http://www.businesswire.com/news/home/20240313456336/en/Builds-Bio-Releases-New-York-London-Life-Sciences-Study-Tour-Research-Report/?feedref=Zd8jjkgYuzBwDixoAdXmJgT1albrG1Eq4mAeVP39211MVCMPSAdgO7NKHMb238WLevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxYvSRPwl8-_l9-Y8T4ahCUme0n00mf9pdzJkOI_RugK2A==

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

REAL ESTATE

One-day event aims to help landlords prepare for regulatory changes

June 17, 2025
GREEN

Are EPCs destined to fail?

June 17, 2025
PRIVATE DEBT

Government’s £39bn housing pledge could unlock 500,000 new affordable homes – JLL

June 17, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

Alithea Genomics Closes CHF 2.8 Million in Seed Financing Extension Led by Novalis Biotech

Cleantech Company Themo Developed a Unique Smart Thermostat Technology That Allows Electrically Heated Premises to Earn Money by Participating in Balancing the Grid

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart